The recent recovery was driven by reports that the Omicron variant of the coronavirus is more contagious but leads to fewer hospital stays and fewer deaths.
(Photo: Reuters)
Frankfurt, New York On the penultimate trading day of the year on Wall Street, the US stock exchanges also gain. The US standard value index Dow Jones rose 0.5 percent to a record high of 36,679.44 points when it opened. The broad S&P 500 also marks a new high. It increases by 0.3 percent to 4808.38 points. The technology-heavy Nasdaq gained about 0.2 percent and initially missed a new high. The three indices have each gained around 20 percent since the beginning of the year.
The lower level of danger of the newly discovered Omikron variant of the coronavirus and the shortening of the quarantine in the US match his forecast that the supply chain disruptions will resolve in early 2022, said investment strategist Scott Chronert from Citigroup.
The titles of Biogen, which were cheaper by six percent, also came under selling pressure. Samsung BioLogics denied a media report about a planned multi-billion dollar takeover of the US pharmaceutical company.
Look at further individual values
Didi: A decline in sales initially sent Didi’s shares, which are listed in the USA, downhill. At the start of the stock market, however, the shares of the Chinese Uber rival rose again by 1.5 Percent. The transport operator is under great pressure from the government in Beijing, which accuses the company of misusing customer data and therefore blocked several Didi apps from being downloaded.
Top jobs of the day
Find the best jobs now and
be notified by email.
Micron: Micron is currently struggling with these problems. The memory chip manufacturer warned of production downtimes in the region’s semiconductor factories due to a pandemic-related lockdown in the Chinese city of Xian. Micron shares then gave way to 2.3 percent.
Biogen: The titles of Biogen, which were cheaper by six percent, also came under selling pressure. Samsung BioLogics denied a media report about a planned multi-billion dollar takeover of the US pharmaceutical company. On Thursday, the title slipped by 5.3 percent.
Johnson & Johnson: Two doses of the corona vaccine from Johnson & Johnson reduced hospital stays caused by the Omicron variant in South Africa by up to 85 percent – an important finding as the vaccine is increasingly used on the continent. The results of the South African Medical Research Council studies could also explain why hospital admissions and deaths do not follow the exponential increase in new cases. Johnson & Johnson shares rise 0.4 percent.
More: These eight stocks are the bearers of hope for the stock market year 2022